Bayern Executives Face Backlash Over Jamal Musiala Contract and Health Status

Bayern Munich midfielder Jamal Musiala suffered another absence seizure ahead of a league match, as club executives faced severe backlash for publicly questioning his high salary.

Bayern Executives Face Backlash Over Jamal Musiala Contract and Health Status
Photo: TheSportsDB / Official Club Media

Bayern Munich midfielder Jamal Musiala suffered another absence seizure last Monday, just four days before stepping off the bench in his side's 1-1 draw against FC Cologne, according to reports published by Bild and Sport1. The medical episode may be linked to a recent adjustment in the pharmaceutical treatment of the 23-year-old Germany international. Despite the incident, medical staff cleared him by Friday, allowing manager Vincent Kompany to deploy him for approximately 20 minutes.

Leadership Under Fire Over Contract Remarks

Shortly after the final whistle, high-ranking club officials publicly discussed Musiala's medical condition and the possibility of reopening his lucrative contract, triggering immediate backlash across German football. Last summer, Musiala collapsed on the pitch twice within four days during pre-season fixtures, later revealing he experienced short neurological disconnects diagnosed as absence seizures. This ongoing health battle follows months of rigorous rehabilitation from a severe fibula and ankle fracture sustained at the FIFA Club World Cup in July 2025. Five months prior to that injury, Bayern extended his contract until the summer of 2030 in an agreement reportedly worth up to 30 million euros per season.

That staggering financial figure took center stage in an interview given by executive board member Karl-Heinz Rummenigge following the Cologne match. Rummenigge questioned whether the player could return to peak form, stating that if Musiala struggles to replicate his pre-injury output, management would need to consult his family and representatives because such massive sums could no longer be justified. When asked about a potential transfer, Rummenigge admitted he could not envision another club acquiring the midfielder under current conditions, calling it a distinct problem.

Institutional Backlash and FIFPRO Condemnation

Rummenigge's remarks marked the third time this month that a senior Bayern executive publicly addressed the player's financial situation. Honorary president Uli Hoeness previously questioned whether Musiala would regain his previous level while noting that the player continues to collect his salary, while CEO Jan-Christian Dreesen suggested that formal talks with the midfielder's entourage might be necessary. The international players' union FIFPRO fiercely condemned the trio, accusing them of a coordinated effort to exert psychological pressure on Musiala during delicate contract circumstances. FIFPRO emphasized that just as a string of exceptional matches does not automatically entitle a player to a pay raise, a medical setback is equally invalid grounds for contract renegotiation.

Public protest reached the club's annual general meeting on Saturday when club member and neurologist Jonathan Hoffmann took the podium to praise the unwavering support shown by manager Vincent Kompany and sporting director Max Eberl. Hoffmann criticized executive leadership for displaying little trace of the renowned Bayern family values, earning widespread applause from the audience. Former club captain Lothar Matthaeus weighed in by noting that he has known Rummenigge for over three decades and that the executive chose his public words very carefully, stressing that Jamal Musiala bears the heaviest burden of the controversy. In response, club president Herbert Hainer addressed the assembly from the stage, assuring members that Musiala will receive all the necessary support and time he requires. CEO Jan-Christian Dreesen also addressed the fallout on the sidelines, firmly rejecting allegations that management attempted to pressure the player and declaring that there is currently no need to discuss the contract.

Related News